Characteristics of type 1 VWD and control participants from which ECFCs were isolated
. | Type 1 VWD (N = 8) . | Controls (N = 4) . |
---|---|---|
Median age (range) | 33.5 (25-64) | 23.5 (21-42) |
Sex (F/M) | 6/2 | 2/2 |
% O-type blood | 83∗ | 75 |
Median baseline VWF:Ag (IU/mL) (range) | 0.43 (0.20-0.53) | 0.73† (0.44-0.87) |
Median baseline VWF activity (IU/mL) (range) | 0.35 (0.28-0.56) | 0.73† (0.42-0.85) |
Median ISTH-BAT Bleeding Score (range) | 9 (4-15) | 2† (0-4) |
. | Type 1 VWD (N = 8) . | Controls (N = 4) . |
---|---|---|
Median age (range) | 33.5 (25-64) | 23.5 (21-42) |
Sex (F/M) | 6/2 | 2/2 |
% O-type blood | 83∗ | 75 |
Median baseline VWF:Ag (IU/mL) (range) | 0.43 (0.20-0.53) | 0.73† (0.44-0.87) |
Median baseline VWF activity (IU/mL) (range) | 0.35 (0.28-0.56) | 0.73† (0.42-0.85) |
Median ISTH-BAT Bleeding Score (range) | 9 (4-15) | 2† (0-4) |